Literature DB >> 22296972

Targeted gonadotrophin stimulation using the PIVET algorithm markedly reduces the risk of OHSS.

John Yovich1, James Stanger, Peter Hinchliffe.   

Abstract

PIVET Medical Centre has developed an empirical algorithm for the dose of FSH administration based upon day-2 FSH, antral follicle count, anti-Müllerian hormone, body mass index, age and smoking parameters in an attempt to reduce the incidence of ovarian hyperstimulation syndrome particularly in at-risk women with elevated antral follicle count and anti-Müllerian hormone. The algorithm utilized the incremental dosage capabilities of the recombinant FSH pens to fine-tune the daily concentration of FSH. Application of the algorithm aimed to minimize any form of excessive follicle recruitment that necessitated increased clinical awareness. The measure used to assess the impact of the algorithm was the number of women who, after oocyte retrieval, were considered to be potentially at risk of any degree of OHSS and were allocated to increased monitoring. Compared with the previous 20-month period, introduction of the algorithm significantly reduced both the incidence of referral for increased monitoring, treatment for OHSS and the incidence of freeze-all cycles (all P < 0.05). This was particularly focused on those considered to be at risk without reducing the fresh cycle pregnancy rate. Copyright Â
© 2011 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22296972     DOI: 10.1016/j.rbmo.2011.11.014

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  10 in total

Review 1.  Dose adjustment of follicle-stimulating hormone (FSH) during ovarian stimulation as part of medically-assisted reproduction in clinical studies: a systematic review covering 10 years (2007-2017).

Authors:  Human Fatemi; Wilma Bilger; Deborah Denis; Georg Griesinger; Antonio La Marca; Salvatore Longobardi; Mary Mahony; Xiaoyan Yin; Thomas D'Hooghe
Journal:  Reprod Biol Endocrinol       Date:  2021-05-11       Impact factor: 5.211

2.  Successful pregnancy and live birth from a hypogonadotropic hypogonadism woman with low serum estradiol concentrations despite numerous oocyte maturations: a case report.

Authors:  Kaori Matsumoto; Kazuhiko Imakawa; Chuyu Hayashi
Journal:  BMC Pregnancy Childbirth       Date:  2017-09-20       Impact factor: 3.007

3.  Live birth outcomes of vitrified embryos generated under growth hormone stimulation are improved for women categorized as poor-prognosis.

Authors:  Kevin N Keane; Yun Ye; Peter M Hinchliffe; Sheena Lp Regan; Satvinder S Dhaliwal; John L Yovich
Journal:  Clin Exp Reprod Med       Date:  2019-11-19

4.  A comparative, observational study evaluating dosing characteristics and ovarian response using the recombinant human follicle-stimulating hormone pen injector with small-dose dial in assisted reproductive technologies treatment in Asia: IMPROVE study.

Authors:  Bum Chae Choi; Canquan Zhou; Hong Ye; Yun Sun; Ying Zhong; Fei Gong; Ivan Sini; Nadezda Abramova; Salvatore Longobardi; Miranda Hickey; Thomas D'Hooghe
Journal:  Reprod Biol Endocrinol       Date:  2022-01-17       Impact factor: 5.211

5.  A new ovarian response prediction index (ORPI): implications for individualised controlled ovarian stimulation.

Authors:  Joao Batista A Oliveira; Ricardo L R Baruffi; Claudia G Petersen; Ana L Mauri; Adriana M Nascimento; Laura Vagnini; Juliana Ricci; Mario Cavagna; Jose G Franco
Journal:  Reprod Biol Endocrinol       Date:  2012-11-21       Impact factor: 5.211

6.  PIVET rFSH dosing algorithms for individualized controlled ovarian stimulation enables optimized pregnancy productivity rates and avoidance of ovarian hyperstimulation syndrome.

Authors:  John L Yovich; Birgit Alsbjerg; Jason L Conceicao; Peter M Hinchliffe; Kevin N Keane
Journal:  Drug Des Devel Ther       Date:  2016-08-10       Impact factor: 4.162

Review 7.  The effect of cigarette smoking, alcohol consumption and fruit and vegetable consumption on IVF outcomes: a review and presentation of original data.

Authors:  Sarah Firns; Vinicius Fernandes Cruzat; Kevin Noel Keane; Karen A Joesbury; Andy H Lee; Philip Newsholme; John L Yovich
Journal:  Reprod Biol Endocrinol       Date:  2015-12-16       Impact factor: 5.211

8.  DHEA Supplementation Confers No Additional Benefit to that of Growth Hormone on Pregnancy and Live Birth Rates in IVF Patients Categorized as Poor Prognosis.

Authors:  Kevin N Keane; Peter M Hinchliffe; Philip K Rowlands; Gayatri Borude; Shanti Srinivasan; Satvinder S Dhaliwal; John L Yovich
Journal:  Front Endocrinol (Lausanne)       Date:  2018-01-31       Impact factor: 5.555

9.  Individualized ovarian stimulation in IVF/ICSI treatment: it is time to stop using high FSH doses in predicted low responders.

Authors:  Jori A Leijdekkers; Helen L Torrance; Nienke E Schouten; Theodora C van Tilborg; Simone C Oudshoorn; Ben Willem J Mol; Marinus J C Eijkemans; Frank J M Broekmans
Journal:  Hum Reprod       Date:  2020-09-01       Impact factor: 6.918

10.  Recombinant Human Follicle-Stimulating Hormone Alfa Dose Adjustment in US Clinical Practice: An Observational, Retrospective Analysis of a Real-World Electronic Medical Records Database.

Authors:  Mary C Mahony; Brooke Hayward; Gilbert L Mottla; Kevin S Richter; Stephanie Beall; G David Ball; Thomas D'Hooghe
Journal:  Front Endocrinol (Lausanne)       Date:  2021-12-09       Impact factor: 5.555

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.